Seres Therapeutics, Inc.
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, …
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Seres Therapeutics, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Seres Therapeutics, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Seres Therapeutics, Inc..